Elevance Health Stock Current Valuation
ELV Stock | USD 402.75 0.79 0.20% |
Valuation analysis of Elevance Health helps investors to measure Elevance Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to climb to about 121.4 B in 2024, whereas Enterprise Value Over EBITDA is likely to drop 7.43 in 2024. Fundamental drivers impacting Elevance Health's valuation include:
Price Book 2.1338 | Enterprise Value 112.7 B | Price Sales 0.5368 | Forward PE 11.5207 | Trailing PE 14.6614 |
Undervalued
Today
Please note that Elevance Health's price fluctuation is very steady at this time. Calculation of the real value of Elevance Health is based on 3 months time horizon. Increasing Elevance Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elevance stock is determined by what a typical buyer is willing to pay for full or partial control of Elevance Health. Since Elevance Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elevance Stock. However, Elevance Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 402.75 | Real 503.89 | Target 570.0 | Hype 400.64 |
The intrinsic value of Elevance Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elevance Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Elevance Health helps investors to forecast how Elevance stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elevance Health more accurately as focusing exclusively on Elevance Health's fundamentals will not take into account other important factors: Elevance Health Company Current Valuation Analysis
Elevance Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Elevance Health Current Valuation | 112.69 B |
Most of Elevance Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevance Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Elevance Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Elevance Health is extremely important. It helps to project a fair market value of Elevance Stock properly, considering its historical fundamentals such as Current Valuation. Since Elevance Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Elevance Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Elevance Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Elevance Current Valuation Historical Pattern
Today, most investors in Elevance Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Elevance Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Elevance Health current valuation as a starting point in their analysis.
Elevance Health Current Valuation |
Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Elevance Health has a Current Valuation of 112.69 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is significantly lower than that of the firm.
Elevance Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevance Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevance Health could also be used in its relative valuation, which is a method of valuing Elevance Health by comparing valuation metrics of similar companies.Elevance Health is currently under evaluation in current valuation category among its peers.
Elevance Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Elevance Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Elevance Health's managers, analysts, and investors.Environmental | Governance | Social |
Elevance Fundamentals
Return On Equity | 0.16 | ||||
Return On Asset | 0.0584 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.04 % | ||||
Current Valuation | 112.69 B | ||||
Shares Outstanding | 231.92 M | ||||
Shares Owned By Insiders | 0.10 % | ||||
Shares Owned By Institutions | 91.69 % | ||||
Number Of Shares Shorted | 3.13 M | ||||
Price To Earning | 19.27 X | ||||
Price To Book | 2.13 X | ||||
Price To Sales | 0.54 X | ||||
Revenue | 171.34 B | ||||
Gross Profit | 40.11 B | ||||
EBITDA | 10.49 B | ||||
Net Income | 5.99 B | ||||
Cash And Equivalents | 7.39 B | ||||
Cash Per Share | 150.32 X | ||||
Total Debt | 25.12 B | ||||
Debt To Equity | 0.66 % | ||||
Current Ratio | 1.35 X | ||||
Book Value Per Share | 188.74 X | ||||
Cash Flow From Operations | 8.06 B | ||||
Short Ratio | 1.33 X | ||||
Earnings Per Share | 27.47 X | ||||
Price To Earnings To Growth | 0.75 X | ||||
Target Price | 520.12 | ||||
Number Of Employees | 104.9 K | ||||
Beta | 0.85 | ||||
Market Capitalization | 93.41 B | ||||
Total Asset | 108.93 B | ||||
Retained Earnings | 31.75 B | ||||
Annual Yield | 0.02 % | ||||
Five Year Return | 1.13 % | ||||
Net Asset | 108.93 B | ||||
Last Dividend Paid | 6.37 |
About Elevance Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevance Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevance Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevance Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.